XML 27 R15.htm IDEA: XBRL DOCUMENT
v3.25.1

Note 7 - Concentrations | 12 Months Ended
--- | ---
Dec. 31, 2024
Notes to Financial Statements |
Concentration Risk Disclosure [Text Block] |
Note 7: | Concentrations
Revenues from customers representing 5% or more of total revenue for the years ended December 31, 2024 and 2023, respectively were:
|  |  | Years Ended December 31, |
Count |  |  | 2024 |  |  | 2023 |
1 |  |  | $ | 536,615 |  |  | $ | 404,097 |
2 |  |  |  | 240,578 |  |  |  | 175,020 |
3 |  |  |  | 155,143 |  |  |  | 141,519 |
4 |  |  |  | - |  |  |  | 78,575 |
5 |  |  |  | - |  |  |  | 75,999 |

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration